Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-06-17 @ 7:17 AM
Study NCT ID:
NCT04075604
Status:
COMPLETED
Last Update Posted:
2022-08-10
First Post:
2019-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA209-7A8
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None